Empowered Patient Podcast

Dr. Robert Cobuzzi, CEO, Diffusion Pharmaceuticals describes the evolution of the thinking about treating hypoxia and low oxygen conditions caused by a variety of diseases and conditions. With modified crocetin derived from the spice saffron harvested from Crocus sativus, Diffusion has come up with a compound Trans-Sodium Crocetinate --TSC--to treat hypoxic conditions related to peripheral artery disease, blockages of peripheral arteries, brain cancer and other types of solid tumors, strokes and respiratory diseases like COVID-19.

@diffusionpharma #crocetinate #TSC #hypoxia #hypoxic #lowoxygen #COVID19

Diffusionpharma.com

Listen to the podcast here

Dr. Robert Cobuzzi, CEO, Diffusion Pharmaceuticals describes the evolution of the thinking about treating hypoxia and low oxygen conditions caused by a variety of diseases and conditions. With modified crocetin derived from the spice saffron harvested from Crocus sativus, Diffusion has come up with a compound Trans-Sodium Crocetinate --TSC--to treat hypoxic conditions related to peripheral artery disease, blockages of peripheral arteries, brain cancer and other types of solid tumors, strokes and respiratory diseases like COVID-19.

@diffusionpharma #crocetinate #TSC #hypoxia #hypoxic #lowoxygen #COVID19

Diffusionpharma.com

Download the transcript here

Dr. Joan Kapusnik-Uner, Vice President Clinical Content, First Databank is an expert on drug labeling and is concerned about opioid misuse and overdoses. She talks about the significance of the AMA recommendation that having an opioid reversal medication called Naloxone be available for all patients prescribed opioid pain relievers in order to really reduce opioid deaths particularly in this time of COVID-19. FIrst Databank has recently published an auxiliary label that goes on an opioid prescription that says the patient should ask the pharmacist about getting Naloxone.

@FDB_US #COVID19 #OpioidEpidemic #OpioidCrisis #Opioids #Naloxone #NaloxoneSavesLives #Overdose #OverdoseAware #MedSafety #DrugSafety

FDBHealth.com

Listen to the podcast here.

Dr. Joan Kapusnik-Uner, Vice President Clinical Content, First Databank is an expert on drug labeling and is concerned about opioid misuse and overdoses. She talks about the significance of the AMA recommendation that having an opioid reversal medication called Naloxone be available for all patients prescribed opioid pain relievers in order to really reduce opioid deaths particularly in this time of COVID-19. FIrst Databank has recently published an auxiliary label that goes on an opioid prescription that says the patient should ask the pharmacist about getting Naloxone.

@FDB_US #COVID19 #OpioidEpidemic #OpioidCrisis #Opioids #Naloxone #NaloxoneSavesLives #Overdose #OverdoseAware #MedSafety #DrugSafety

FDBHealth.com

Download the transcript here.

Bob Hutchens, President and CEO, StemBioSys talks about their work building a set of tools that are being used around the world by pharmaceutical companies in early-stage drug discovery. CELLvo and CELLvo Matrix Plus are technologies that grow cells from amniotic fluid from natural births and reverse-engineer them into pluripotent stem cells. Overcoming challenges of turning these cells into cardiomyocyte cells researchers are able to more quickly and accurately determine drug safety on mature adult cardiomyocyte. This technology can produce more accurate readings than animal models and more quickly produce cells that are a strong predictor of drug efficacy and drug safety.

@StemBioSys #StemBioSys #CellvoMatrixPlus #DrugToxicityScreening #Stemcells

StemBioSys.com

Listen to the podcast here

Bob Hutchens, President and CEO, StemBioSys talks about their work building a set of tools that are being used around the world by pharmaceutical companies in early-stage drug discovery. CELLvo and CELLvo Matrix Plus are technologies that grow cells from amniotic fluid from natural births and reverse-engineer them into pluripotent stem cells. Overcoming challenges of turning these cells into cardiomyocyte cells researchers are able to more quickly and accurately determine drug safety on mature adult cardiomyocyte. This technology can produce more accurate readings than animal models and more quickly produce cells that are a strong predictor of drug efficacy and drug safety.

@StemBioSys #StemBioSys #CellvoMatrixPlus #DrugToxicityScreening #Stemcells

StemBioSys.com

Download the transcript here

Dr. Caroline DeFilippo, practicing internist and associate medical director, CareMount Medical addresses the need for healthcare professionals to have end-of-life conversations with patients sooner than later. With tips for practitioners, Caroline addresses the need to see the whole patient not just the body parts and how palliative care conversations are becoming more necessary with the impact of COVID-19 on seniors as well as those who think that they are never going to die.

@caremountmed #endoflife #hospice #COVID19

Caremountmedical.com

Listen to the podcast here

Dr. Caroline DeFilippo, practicing internist and associate medical director, CareMount Medical addresses the need for healthcare professionals to have end-of-life conversations with patients sooner than later. With tips for practitioners, Caroline addresses the need to see the whole patient not just the body parts and how palliative care conversations are becoming more necessary with the impact of COVID-19 on seniors as well as those who think that they are never going to die.

@caremountmed #endoflife #hospice #COVID19

Caremountmedical.com

Download the transcript here

Cathy Kuhn PharmD, Director of Strategy Consulting, Updox has a deep understanding of the communications needs of pharmacists, healthcare providers, and patients and what issues can be addressed by moving from paper to digital. Updox is creating a secure virtual care online environment to encourage the reduction of reliance on paper forms and faxes, a shift which is gaining more wide-spread acceptance particularly in the age of COVID-19.

@Updox #pharmacists #Pharmacy #PharmacistsProvideCare #digitalhealth #telehealth #COVID19

Updox.com

Listen to the podcast here

Cathy Kuhn PharmD, Director of Strategy Consulting, Updox has a deep understanding of the communications needs of pharmacists, healthcare providers, and patients and what issues can be addressed by moving from paper to digital. Updox is creating a secure virtual care online environment to encourage the reduction of reliance on paper forms and faxes, a shift which is gaining more wide-spread acceptance particularly in the age of COVID-19.

@Updox #pharmacists #Pharmacy #PharmacistsProvideCare #digitalhealth #telehealth #COVID19

Updox.com

Download the transcript here